Previous close | 5.20 |
Open | 5.68 |
Bid | 5.14 x 500 |
Ask | 5.17 x 100 |
Day's range | 5.04 - 5.77 |
52-week range | 4.71 - 12.43 |
Volume | |
Avg. volume | 2,098,319 |
Market cap | 739.408M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Aurinia (AUPH) delivered earnings and revenue surprises of 82.35% and 8.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals...
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]